Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The Inv(16) Oncogene CBFB::MYH11 is Required for the Survival of Leukemia Cells in the Blood and Spleen, but not the Bone Marrow.
Journal: Oncogene
Published: December 02, 2025
PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4.
Journal: Molecular cancer therapeutics
Published: August 21, 2025
PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
The Splicing Factor PTBP1 interacts with RUNX1 and is Required for Leukemia Cell Survival.
Journal: bioRxiv : the preprint server for biology
Published: June 06, 2025
The splicing factor PTBP1 interacts with RUNX1 and is required for leukemia cell survival.
Journal: Leukemia
Published: May 16, 2025
Loss of the Inv(16) Oncogene CBFB::MYH11 Eliminates Leukemia from the Blood and Spleen, but not the Bone Marrow.
Journal: bioRxiv : the preprint server for biology
Published: January 13, 2025
Programming the elongation of mammalian cell aggregates with synthetic gene circuits.
Journal: bioRxiv : the preprint server for biology
Published: December 23, 2024
Programming Juxtacrine-Based Synthetic Signaling Networks in a Cellular Potts Framework.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 12, 2024
Design and mathematical analysis of activating transcriptional amplifiers that enable modular temporal control in synthetic juxtacrine circuits.
Journal: Synthetic and systems biotechnology
Published: June 03, 2023
Parameterized Computational Framework for the Description and Design of Genetic Circuits of Morphogenesis Based on Contact-Dependent Signaling and Changes in Cell-Cell Adhesion.
Journal: ACS synthetic biology
Published: April 01, 2022
Synthetic Immunotherapy: Programming Immune Cells with Novel and Sophisticated Logic Capabilities.
Journal: Transplantation and cellular therapy
Published: February 22, 2022
Last Updated: 09/26/2026